Back to search

Article

A Potential Beta-hydroxybutyrate Therapy for Duchenne Muscular Dystrophy in Disease Models

2025-10-19

Abstract excerpt

Duchenne muscular dystrophy (DMD) is a common and lethal muscular degenerative disorder caused by mutations in the Dystrophin gene. Patients with DMD suffer progressive motor and respiratory decline over time and exhibit mitochondria defects at the cellular level, contributing to their reduced life expectancy. Despite extensive efforts, effective treatments for DMD remain unavailable. This study aims to explore a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f39b4c8-6e0d-5ed3-b964-0d7466b31b91
DOI
10.1101/2025.10.18.683257
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Potential Beta-hydroxybutyrate Therapy for Duchenne Muscular Dystrophy in Disease ModelsDOI 10.1101/2025.10.18.683257
Select a neighboring publication to make it the new centre.